Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection

Science Translational Medicine

Volumn 8, Issue 358, 2016, Pages

  Muenchhoff, Maximilian ^a,b,c,d   Adland, Emily ^a   Karimanzira, Owen ^e   Crowther, Carol ^e   Pace, Matthew ^f,g,h   Csala, Anna ^a   Leitman, Ellen ^a   Moonsamy, Angeline ^a   McGregor, Callum ^a,b   Hurst, Jacob ⁱ   Groll, Andreas ^c   Mori, Masahiko ^a   Sinmyee, Smruti ^a   Thobakgale, Christina ^b   Tudor Williams, Gareth ^j   Prendergast, Andrew J ^k   Kloverpris, Henrik ^b,l   Roider, Julia ^a,b   Leslie, Alasdair ^b   Shingadia, Delane ^m   Brits, Thea ⁿ   Daniels, Samantha ⁿ   Frater, John ^f,g,h   Willberg, Christian B ^g,h   Walker, Bruce D ^b,o   Ndung'u, Thumbi ^b,o,p   Jooste, Pieter ⁿ   Moore, Penny L ^e,q,r   Morris, Lynn ^e,q,r   Goulder, Philip ^e,q,r   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF MUNICH   (Germany)

^d Partner Site Munich   (Germany)

^e NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h Oxford National Institute for Health Research Biomedical Research Centre   (United Kingdom)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^l UNIVERSITY OF COPENHAGEN   (Denmark)

^m GREAT ORMOND STREET HOSPITAL   (United Kingdom)

ⁿ Kimberley Hospital   (South Africa)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^q UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^r UNIVERSITY OF KWAZULU NATAL   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; FATTY ACID BINDING PROTEIN 2; GAMMA INTERFERON; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CERCOCEBUS ATYS; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; FLUORESCENCE ACTIVATED CELL SORTING; GENERAL ASPECTS OF DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE ACTIVATION; IMMUNE RESPONSE; IMMUNOLOGICAL FEATURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; MISCELLANEOUS NAMED GROUPS; MOLECULAR DYNAMICS; NONPATHOGENESIS; NONPATHOGENIC SIMIAN IMMUNODEFICIENCY VIRUS INFECTION; NONPROGRESSING HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OBSERVATIONAL STUDY; PEDIATRIC NONPROGRESSOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIREMIA; VIRUS LOAD; VIRUS NEUTRALIZATION; ANIMAL; BLOOD; CELL DIFFERENTIATION; DISEASE EXACERBATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; SPECIES DIFFERENCE;

ANIMALS; ANTIBODIES, NEUTRALIZING; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHILD; DISEASE PROGRESSION; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; RECEPTORS, CCR5; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SPECIES SPECIFICITY; VIRAL LOAD; VIREMIA;

EID: 84989829797     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aag1048     Document Type: Article

References (66)

1. + T cell gains in human immunodeficiency virusinfected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 187, 1534-1543 (2003).
2. + T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197, 126-133 (2008).
3. S. Subramanian, A. Tawakol, T. H. Burdo, S. Abbara, J. Wei, J. Vijayakumar, E. Corsini, A. Abdelbaky, M. V. Zanni, U. Hoffmann, K. C. Williams, J. Lo, S. K. Grinspoon, Arterial inflammation in patients with HIV. JAMA 308, 379-386 (2012).
4. M. M. Lederman, N. T. Funderburg, R. P. Sekaly, N. R. Klatt, P. W. Hunt, Residual immune dysregulation syndrome in treated HIV infection. Adv. Immunol. 119, 51-83 (2013).
5. T. H. Finkel, G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, A. Kupfer, Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-And SIV-infected lymph nodes. Nat. Med. 1, 129-134 (1995).
6. + T-cell changes independent of viral load. Blood 104, 942-947 (2004).
7. G. Silvestri, D. L. Sodora, R. A. Koup, M. Paiardini, S. P. O'Neil, H. M. McClure, S. I. Staprans, M. B. Feinberg, Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18, 441-452 (2003).
8. S. Van De Woude, C. Apetrei, Going wild: Lessons from naturally occurring T-lymphotropic lentiviruses. Clin. Microbiol. Rev. 19, 728-762 (2006).
9. A. Chahroudi, S. E. Bosinger, T. H. Vanderford, M. Paiardini, G. Silvestri, Natural SIV hosts: Showing AIDS the door. Science 335, 1188-1193 (2012).
10. P. J. Goulder, S. R. Lewin, E. M. Leitman, Paediatric HIV infection: The potential for cure. Nat. Rev. Immunol. 16, 259-271 (2016).
11. S. Blanche, M.-L. Newell, M.-J. Mayaux, D. T. Dunn, J. P. Teglas, C. Rouzioux, C. S. Peckham, Morbidity and mortality in European children vertically infected by HIV-1: The French Pediatric HIV Infection Study Group and European Collaborative Study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14, 442-450 (1997).
12. M.-L. Newell, H. Coovadia, M. Cortina-Borja, N. Rollins, P. Gaillard, F. Dabis; Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children, Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis. Lancet 364, 1236-1243 (2004).
13. W. Mphatswe, N. Blanckenberg, G. Tudor-Williams, A. Prendergast, C. Thobakgale, N. Mkhwanazi, N. McCarthy, B. D. Walker, P. Kiepiela, P. Goulder, High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS 21, 1253-1261 (2007).
14. M. E. Paul, C. Mao, M. Charurat, L. Serchuck, M. Foca, K. Hayani, E. L. Handelsman, C. Diaz, K. McIntosh, W. T. Shearer; Women and Infants Transmission Study, Predictors of immunologic long-Term nonprogression in HIV-infected children: Implications for initiating therapy. J. Allergy Clin. Immunol. 115, 848-855 (2005).
15. + T cells is associated with lack of progression in viremic individuals. Plos Pathog. 10, e1004345 (2014).
16. M. Rotger, J. Dalmau, A. Rauch, P. McLaren, S. E. Bosinger, R. Martinez, N. G. Sandler, A. Roque, J. Liebner, M. Battegay, E. Bernasconi, P. Descombes, I. Erkizia, J. Fellay, B. Hirschel, J. M. Miró, E. Palou, M. Hoffmann, M. Massanella, J. Blanco, M. Woods, H. F. Günthard, P. de Bakker, D. C. Douek, G. Silvestri, J. Martinez-Picado, A. Telenti, Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J. Clin. Invest. 121, 2391-2400 (2011).
17. J. Ananworanich, T. Apornpong, P. Kosalaraksa, T. Jaimulwong, R. Hansudewechakul, C. Pancharoen, T. Bunupuradah, M. Chandara, T. Puthanakit, C. Ngampiyasakul, J. Wongsawat, S. Kanjanavanit, W. Luesomboon, P. Klangsinsirikul, N. Ngo-Giang-Huong, S. J. Kerr, S. Ubolyam, T. Mengthaisong, R. S. Gelman, K. Pattanapanyasat, V. Saphonn, K. Ruxrungtham, W. T. Shearer; PREDICT Study Group, Characteristics of lymphocyte subsets in HIV-infected, long-Term nonprogressor, and healthy Asian children through 12 years of age. J. Allergy Clin. Immunol. 126, 1294-1301.e10 (2010).
18. I. Ssewanyana, M. Elrefaei, G. Dorsey, T. Ruel, N. G. Jones, A. Gasasira, M. Kamya, J. Nakiwala, J. Achan, E. Charlebois, D. Havlir, H. Cao, Profile of T cell immune responses in HIV-infected children from Uganda. J. Infect. Dis. 196, 1667-1670 (2007).
19. F. Pereyra, M. M. Addo, D. E. Kaufmann, Y. Liu, T. Miura, A. Rathod, B. Baker, A. Trocha, R. Rosenberg, E. Mackey, P. Ueda, Z. Lu, D. Cohen, T. Wrin, C. J. Petropoulos, E. S. Rosenberg, B. D. Walker, Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197, 563-571 (2008).
20. E. Adland, P. Paioni, C. Thobakgale, L. Laker, L. Mori, M. Muenchhoff, A. Csala, M. Clapson, J. Flynn, V. Novelli, J. Hurst, V. Naidoo, R. Shapiro, K.-H. G. Huang, J. Frater, A. Prendergast, J. G. Prado, T. Ndung'u, B. D. Walker, M. Carrington, P. Jooste, P. J. R. Goulder, Discordant impact of HLA on viral replicative capacity and disease progression in pediatric and adult HIV infection. Plos Pathog. 11, e1004954 (2015).
21. P. J. R. Goulder, B. D. Walker, HIV and HLA class I: An evolving relationship. Immunity 37, 426-440 (2012).
22. R. Dunham, P. Pagliardini, S. Gordon, B. Sumpter, J. Engram, A. Moanna, M. Paiardini, J. N. Mandl, B. Lawson, S. Garg, H. M. McClure, Y.-X. Xu, C. Ibegbu, K. Easley, N. Katz, I. Pandrea, C. Apetrei, D. L. Sodora, S. I. Staprans, M. B. Feinberg, G. Silvestri, The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 108, 209-217 (2006).
23. + T cells are associated with limited CCR5 expression. Nat. Med. 17, 830-836 (2011).
24. W. T. Shearer, H. M. Rosenblatt, R. S. Gelman, R. Oyomopito, S. Plaeger, E. R. Stiehm, D. W. Wara, S. D. Douglas, K. Luzuriaga, E. J. McFarland, R. Yogev, M. H. Rathore, W. Levy, B. L. Graham, S. A. Spector; Pediatric AIDS Clinical Trials Group, Lymphocyte subsets in healthy children from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 study. J. Allergy Clin. Immunol. 112, 973-980 (2003).
25. E. S. Lugada, J. Mermin, F. Kaharuza, E. Ulvestad, W. Were, N. Langeland, B. Asjo, S. Malamba, R. Downing, Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin. Diagn. Lab. Immunol. 11, 29-34 (2004).
26. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126, 946-954 (1997).
27. J. M. Brenchley, D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, B. R. Blazar, B. Rodriguez, L. Teixeira-Johnson, A. Landay, J. N. Martin, F. M. Hecht, L. J. Picker, M. M. Lederman, S. G. Deeks, D. C. Douek, Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006).
28. N. G. Sandler, H. Wand, A. Roque, M. Law, M. C. Nason, D. E. Nixon, C. Pedersen, K. Ruxrungtham, S. R. Lewin, S. Emery, J. D. Neaton, J. M. Brenchley, S. G. Deeks, I. Sereti, D. C. Douek; INSIGHT SMART Study Group, Plasma levels of soluble CD14 independently predict mortality in HIV infection. J. Infect. Dis. 203, 780-790 (2011).
29. P. W. Hunt, E. Sinclair, B. Rodriguez, C. Shive, B. Clagett, N. Funderburg, J. Robinson, Y. Huang, L. Epling, J. N. Martin, S. G. Deeks, C. L. Meinert, M. L. Van Natta, D. A. Jabs, M. M. Lederman, Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J. Infect. Dis. 210, 1228-1238 (2014).
30. E. J. Wherry, M. Kurachi, Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486-499 (2015).
31. M. Friendly, Corrgrams: Exploratory displays for correlation matrices. Am. Stat. 56, 316-324 (2002).
32. P. McCullagh, J. A. Nelder, Generalized Linear Models (Chapman & Hall, ed. 2, 1989).
33. R. Tibshirani, Regression shrinkage and selection via the lasso. J. R. Stat. Soc. B Methodol. 58, 267-288 (1996).
34. J. Friedman, T. Hastie, R. Tibshirani, Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1-22 (2010).
35. J. J. Goeman, L1 penalized estimation in the Cox proportional hazards model. Biom. J. 52, 70-84 (2010).
36. L. Meier, S. van de Geer, P. Bühlmann, The group lasso for logistic regression. J. R. Stat. Soc. B Methodol. 70, 53-71 (2008).
37. B. Li, K. Stefano-Cole, D. M. Kuhrt, S. N. Gordon, J. G. Else, J. Mulenga, S. Allen, D. L. Sodora, G. Silvestri, C. A. Derdeyn, Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies. J. Virol. 84, 6248-6253 (2010).
38. W. Fischer, C. Apetrei, M. L. Santiago, Y. Li, R. Gautam, I. Pandrea, G. M. Shaw, B. H. Hahn, N. L. Letvin, G. J. Nabel, B. T. Korber, Distinct evolutionary pressures underlie diversity in simian immunodeficiency virus and human immunodeficiency virus lineages. J. Virol. 86, 13217-13231 (2012).
39. K. M. Kilgore, M. K. Murphy, S. L. Burton, K. S. Wetzel, S. A. Smith, P. Xiao, S. Reddy, N. Francella, D. L. Sodora, G. Silvestri, K. S. Cole, F. Villinger, J. E. Robinson, B. Pulendran, E. Hunter, R. G. Collman, R. R. Amara, C. A. Derdeyn, Characterization and implementation of a diverse simian immunodeficiency virus SIVsm envelope panel in the assessment of neutralizing antibody breadth elicited in rhesus macaques by multimodal vaccines expressing the SIVmac239 envelope. J. Virol. 89, 8130-8151 (2015).
40. D. N. Sather, J. Armann, L. K. Ching, A. Mavrantoni, G. Sellhorn, Z. Caldwell, X. Yu, B. Wood, S. Self, S. Kalams, L. Stamatatos, Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83, 757-769 (2009).
41. + T cell decline and high viral load during acute infection. J. Virol. 85, 4828-4840 (2011).
42. L. Goo, V. Chohan, R. Nduati, J. Overbaugh, Early development of broadly neutralizing antibodies in HIV-1-infected infants. Nat. Med. 20, 655-658 (2014).
43. C. A. Derdeyn, P. L. Moore, L. Morris, Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection. Curr. Opin. HIV AIDS 9, 210-216 (2014).
44. P. Kiepiela, K. Ngumbela, C. Thobakgale, D. Ramduth, I. Honeyborne, E. Moodley, S. Reddy, C. de Pierres, Z. Mncube, N. Mkhwanazi, K. Bishop, M. van der Stok, K. Nair, N. Khan, H. Crawford, R. Payne, A. Leslie, J. Prado, A. Prendergast, J. Frater, N. McCarthy, C. Brander, G. H. Learn, D. Nickle, C. Rousseau, H. Coovadia, J. I. Mullins, D. Heckerman, B. D. Walker, P. Goulder, CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13, 46-53 (2007).
45. D. Ma, A. Jasinska, J. Kristoff, J. P. Grobler, T. Turner, Y. Jung, C. Schmitt, K. Raehtz, F. Feyertag, N. Martinez Sosa, V. Wijewardana, D. S. Burke, D. L. Robertson, R. Tracy, I. Pandrea, N. Freimer, C. Apetrei; International Vervet Research Consortium, SIVagm infection in wild African green monkeys from South Africa: Epidemiology, natural history, and evolutionary considerations. Plos Pathog. 9, e1003011 (2013).
46. A. Chahroudi, E. Cartwright, S. T. Lee, M. Mavigner, D. G. Carnathan, B. Lawson, P. M. Carnathan, T. Hashempoor, M. K. Murphy, T.Meeker, S. Ehnert, C. Souder, J.G. Else, J. Cohen, R.G. Collman, T. H. Vanderford, S. R. Permar, C. A. Derdeyn, F. Villinger, G. Silvestri, Target cell availability, rather than breast milk factors, dictates mother-To-infant transmission of SIV in sooty mangabeys and rhesus macaques. Plos Pathog. 10, e1003958 (2014).
47. C. S. McGary, B. Cervasi, A. Chahroudi, L. Micci, J. Taaffe, T. Meeker, G. Silvestri, M. P. Davenport, M. Paiardini, Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques. J. Virol. 88, 4533-4542 (2014).
48. N. Chomont, M. El-Far, P. Ancuta, L. Trautmann, F. A. Procopio, B. Yassine-Diab, G. Boucher, M.-R. Boulassel, G. Ghattas, J. M. Brenchley, T. W. Schacker, B. J. Hill, D. C. Douek, J.-P. Routy, E. K. Haddad, R.-P. Sékaly, HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893-900 (2009).
49. + T cells with stem cell-like properties. Nat. Med. 20, 139-142 (2014).
50. S. Eriksson, E. H. Graf, V. Dahl, M. C. Strain, S. A. Yukl, E. S. Lysenko, R. J. Bosch, J. Lai, S. Chioma, F. Emad, M. Abdel-Mohsen, R. Hoh, F. Hecht, P. Hunt, M. Somsouk, J. Wong, R. Johnston, R. F. Siliciano, D. D. Richman, U. O'Doherty, S. Palmer, S. G. Deeks, J. D. Siliciano, Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. Plos Pathog. 9, e1003174 (2013).
51. Y.-C. Ho, L. Shan, N. N. Hosmane, J. Wang, S. B. Laskey, D. I. S. Rosenbloom, J. Lai, J. N. Blankson, J. D. Siliciano, R. F. Siliciano, Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540-551 (2013).
52. J. P. Williams, J. Hurst, W. Stöhr, N. Robinson, H. Brown, M. Fisher, S. Kinloch, D. Cooper, M. Schechter, G. Tambussi, S. Fidler, M. Carrington, A. Babiker, J. Weber, K. K. Koelsch, A. D. Kelleher, R. E. Phillips, J. Frater; SPARTAC Trial Investigators, HIV-1 DNA predicts disease progression and post-Treatment virological control. E-Life 3, e03821 (2014).
53. M. Kiselinova, W. De Spiegelaere, M. J. Buzon, E. Malatinkova, M. Lichterfeld, L. Vandekerckhove, Integrated and total HIV-1 DNA predict ex vivo viral outgrowth. Plos Pathog. 12, e1005472 (2016).
54. P. Kiepiela, A. J. Leslie, I. Honeyborne, D. Ramduth, C. Thobakgale, S. Chetty, P. Rathnavalu, C. Moore, K. J. Pfafferott, L. Hilton, P. Zimbwa, S. Moore, T. Allen, C. Brander, M. M. Addo, M. Altfeld, I. James, S. Mallal, M. Bunce, L. D. Barber, J. Szinger, C. Day, P. Klenerman, J. Mullins, B. Korber, H. M. Coovadia, B. D. Walker, P. J. R. Goulder, Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432, 769-775 (2004).
55. X. Wei, J. M. Decker, S. Wang, H. Hui, J. C. Kappes, X. Wu, J. F. Salazar-Gonzalez, M. G. Salazar, J. M. Kilby, M. S. Saag, N. L. Komarova, M. A. Nowak, B. H. Hahn, P. D. Kwong, G. M. Shaw, Antibody neutralization and escape by HIV-1. Nature 422, 307-312 (2003).
56. Z. Euler, M. J. van Gils, E. M. Bunnik, P. Phung, B. Schweighardt, T. Wrin, H. Schuitemaker, Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. J. Infect. Dis. 201, 1045-1053 (2010).
57. A. J. Prendergast, P. Klenerman, P. J. R. Goulder, The impact of differential antiviral immunity in children and adults. Nat. Rev. Immunol. 12, 636-648 (2012).
58. C. T. Ng, J. P. Jaworski, P. Jayaraman, W. F. Sutton, P. Delio, L. Kuller, D. Anderson, G. Landucci, B. A. Richardson, D. R. Burton, D. N. Forthal, N. L. Haigwood, Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infantmacaques. Nat. Med. 16, 1117-1119 (2010).
59. A. J. Hessell, J. P. Jaworski, E. Epson, K. Matsuda, S. Pandey, C. Kahl, J. Reed, W. F. Sutton, K. B. Hammond, T. A. Cheever, P. T. Barnette, A. W. Legasse, S. Planer, J. J. Stanton, A. Pegu, X. Chen, K. Wang, D. Siess, D. Burke, B. S. Park, M. K. Axthelm, A. Lewis, V. M. Hirsch, B. S. Graham, J. R. Mascola, J. B. Sacha, N. L. Haigwood, Early short-Term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nat. Med. 22, 362-368 (2016).
60. S. Crotty, Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621-663 (2011).
61. A. Meier, J. J. Chang, E. S. Chan, R. B. Pollard, H. K. Sidhu, S. Kulkarni, T. F. Wen, R. J. Lindsay, L. Orellana, D. Mildvan, S. Bazner, H. Streeck, G. Alter, J. D. Lifson, M. Carrington, R. J. Bosch, G. K. Robbins, M. Altfeld, Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat. Med. 15, 955-959 (2009).
62. + T cells in vivo renders African green monkeys resistant to progressive SIVagm infection. Nat. Med. 15, 879-885 (2009).
63. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5, 518-525 (1999).
64. W. A. Hanekom, J. Hughes, M. Mavinkurve, M. Mendillo, M. Watkins, H. Gamieldien, S. J. Gelderbloem, M. Sidibana, N. Mansoor, V. Davids, R. A. Murray, A. Hawkridge, P. A. J. Haslett, S. Ress, G. D. Hussey, G. Kaplan, Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J. Immunol. Methods 291, 185-195 (2004).
65. D. C. Montefiori, Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr. Protoc. Immunol. Chapter 12, Unit 12.11 (2005).
66. J. M. Brenchley, B. J. Hill, D. R. Ambrozak, D. A. Price, F. J. Guenaga, J. P. Casazza, J. Kuruppu, J. Yazdani, S. A. Migueles, M. Connors, M. Roederer, D. C. Douek, R. A. Koup, T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis. J. Virol. 78, 1160-1168 (2004).